Cargando…

A triple drug combination as a novel anti-glioma therapy?

Detalles Bibliográficos
Autores principales: Zhang, Yiru, Karpel-Massler, Georg, Siegelin, Markus D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254665/
https://www.ncbi.nlm.nih.gov/pubmed/30515262
http://dx.doi.org/10.18632/oncotarget.26279
_version_ 1783373775608217600
author Zhang, Yiru
Karpel-Massler, Georg
Siegelin, Markus D.
author_facet Zhang, Yiru
Karpel-Massler, Georg
Siegelin, Markus D.
author_sort Zhang, Yiru
collection PubMed
description
format Online
Article
Text
id pubmed-6254665
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-62546652018-12-04 A triple drug combination as a novel anti-glioma therapy? Zhang, Yiru Karpel-Massler, Georg Siegelin, Markus D. Oncotarget Editorial Impact Journals LLC 2018-11-06 /pmc/articles/PMC6254665/ /pubmed/30515262 http://dx.doi.org/10.18632/oncotarget.26279 Text en Copyright: © 2018 Zhang et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Editorial
Zhang, Yiru
Karpel-Massler, Georg
Siegelin, Markus D.
A triple drug combination as a novel anti-glioma therapy?
title A triple drug combination as a novel anti-glioma therapy?
title_full A triple drug combination as a novel anti-glioma therapy?
title_fullStr A triple drug combination as a novel anti-glioma therapy?
title_full_unstemmed A triple drug combination as a novel anti-glioma therapy?
title_short A triple drug combination as a novel anti-glioma therapy?
title_sort triple drug combination as a novel anti-glioma therapy?
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254665/
https://www.ncbi.nlm.nih.gov/pubmed/30515262
http://dx.doi.org/10.18632/oncotarget.26279
work_keys_str_mv AT zhangyiru atripledrugcombinationasanovelantigliomatherapy
AT karpelmasslergeorg atripledrugcombinationasanovelantigliomatherapy
AT siegelinmarkusd atripledrugcombinationasanovelantigliomatherapy
AT zhangyiru tripledrugcombinationasanovelantigliomatherapy
AT karpelmasslergeorg tripledrugcombinationasanovelantigliomatherapy
AT siegelinmarkusd tripledrugcombinationasanovelantigliomatherapy